Metropolitan Life Insurance Company (MetLife)’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-29,382
Closed -$1.57M 2747
2016
Q1
$1.57M Buy
29,382
+1,031
+4% +$76.1K 0.01% 977
2015
Q4
$3.2M Hold
28,351
0.02% 702
2015
Q3
$3.34M Sell
28,351
-181
-0.6% -$23.6K 0.02% 689
2015
Q2
$2.21M Buy
28,532
+2,546
+10% +$167K 0.02% 933
2015
Q1
$1.5M Hold
25,986
0.01% 996
2014
Q4
$838K Buy
25,986
+956
+4% +$28.7K 0.01% 1449
2014
Q3
$612K Buy
25,030
+2,021
+9% +$41.1K ﹤0.01% 1592
2014
Q2
$408K Hold
23,009
﹤0.01% 1988
2014
Q1
$460K Hold
23,009
﹤0.01% 1867
2013
Q4
$386K Hold
23,009
﹤0.01% 1997
2013
Q3
$244K Buy
+23,009
New +$201K ﹤0.01% 2275

Other funds holding ANAC

Metropolitan Life Insurance Company (MetLife)'s ANAC Position: Q2 2016 in Review

Metropolitan Life Insurance Company (MetLife) sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 29,382 shares — an estimated $1.57M sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in ANAC in Q3 2013 and held it in 11 quarters. The position peaked at $3.34M in Q3 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 29,382 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $1.57M.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in ANACOR PHARMACEUTICALS INC COM in Q3 2013 and held it in 11 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s ANACOR PHARMACEUTICALS INC COM position peaked at $3.34M in Q3 2015.
  • 2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2016, filed 16 Aug 2016.